Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates

Eckert & Ziegler (ISIN DE0005659700, SDAX) and ARTBIO, Inc. (ARTBIO), a clinical-stage biotechnology company specializing in the development of a new class of alpha radioligand therapies (ARTs), have entered into a strategic manufacturing and supply…

2 Min
More

How much does biodiversity loss contribute to the spread of new infectious diseases?

Researchers widely agree that loss of biodiversity due to factors such as human interference with ecosystems contributes to the transmission of pathogens from animals to humans, which is known as a zoonosis. But how large is this effect? Quantifying…

4 Min
More

Lindis Blood Care announces last patient out in multicenter clinical certification study REMOVE with CATUVAB® to eliminate tumor cells from surgical blood

Lindis Blood Care, a company aiming to set a new standard for blood management during cancer surgeries with its medical device CATUVAB® for the removal of tumor cells from surgical shed blood, today announced that the last patient in its…

3 Min
More

A neuromuscular model for drug development

In neuromuscular diseases, neurons and muscle cells stop communicating properly. Researchers led by Mina Gouti can now model this in 2D in a culture dish. Writing about their findings in “Nature Communications”, they say the new model promises to…

3 Min
More

Scientists of the Max Delbrück Center describe the role one enzyme plays in removing waste DNA or RNA remains in cells

If waste DNA or RNA remains in cells, it can lead to diseases such as Alzheimer’s and autoimmune conditions. Writing in Nucleic Acids Research, scientists led by Oliver Daumke of the Max Delbrück Center describe the role one enzyme plays in removing…

3 Min
More

Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening

WILMINGTON, Mass. & BERLIN--(BUSINESS WIRE)--Dec. 12, 2023-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an agreement with CELLphenomics, a service-based biotechnology company that is using 3D…

3 Min
More

ProBioGen was Granted a New Patent for DirectedLuck® Transposase Technology

Berlin, Germany - December 14th, 2023

1 Min
More

Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases

Generation of Longitudinal Panomics Data to improve the Disease understanding of Anca-Associated Vasculitis

Charité – Universitätsmedizin Berlin will collect Biosamples from Anca-Associated Vasculitis Patients

Evotec will Leverage its Unique…

3 Min
More

Novozymes and Chr. Hansen announce name of future combined company; Novonesis

Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in…

9 Min
More

Special Topic | Cardiovascular health in Berlin-Brandenburg

Whether heart attack, stroke or other heart problems: Cardiovascular diseases are the most common cause of death in Germany. Even though mortality has fallen in recent years thanks to new examination and treatment methods, there is still a lot to be…

16 Min
More
Show more items